Literature DB >> 17445934

Pediatric nonalcoholic fatty liver disease (NAFLD): a "growing" problem?

Eve A Roberts1.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) can affect both adults and children. With the current worldwide epidemic of pediatric obesity, pediatric NAFLD is increasingly being diagnosed. It is not exactly identical to NAFLD in adults, and these differences may be due in part to the occurrence of hepatic metabolic derangements typical of NAFLD during periods of active growth (infancy, mid-childhood and puberty). The natural history of pediatric NAFLD is not yet known; however, children with pediatric NAFLD can develop cirrhosis. Although details of disease mechanism in pediatric NAFLD remain unclear, hyperinsulinemia with insulin resistance appears to be critical. Determining the pathogenesis of pediatric NAFLD is likely to enhance our understanding of NAFLD in all age groups and may identify new treatment opportunities. Finding effective ways to prevent pediatric NAFLD is an important issue for children's health.

Entities:  

Mesh:

Year:  2007        PMID: 17445934     DOI: 10.1016/j.jhep.2007.03.003

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  50 in total

1.  The role of pro/anti-inflammatory adipokines on bone metabolism in NAFLD obese adolescents: effects of long-term interdisciplinary therapy.

Authors:  Raquel M S Campos; Aline de Piano; Patrícia L da Silva; June Carnier; Priscila L Sanches; Flávia C Corgosinho; Deborah C L Masquio; Marise Lazaretti-Castro; Lila M Oyama; Cláudia M O Nascimento; Lian Tock; Marco Túlio de Mello; Sergio Tufik; Ana R Dâmaso
Journal:  Endocrine       Date:  2012-08       Impact factor: 3.633

Review 2.  Fatty liver in childhood.

Authors:  Yesim Ozturk; Ozlem Bekem Soylu
Journal:  World J Hepatol       Date:  2014-01-27

3.  Sex modifies the consequences of extended fructose consumption on liver health, motor function, and physiological damage in rats.

Authors:  Molly M Hyer; Samya K Dyer; Alix Kloster; Anum Adrees; Thomas Taetzsch; Jonathan Feaster; Gregorio Valdez; Gretchen N Neigh
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-09-25       Impact factor: 3.619

Review 4.  Nonalcoholic fatty liver disease: diagnosis and relation to metabolic syndrome and approach to treatment.

Authors:  Steven D Lidofsky
Journal:  Curr Diab Rep       Date:  2008-02       Impact factor: 4.810

5.  The relationship between pediatric nonalcoholic fatty liver disease and cardiovascular risk factors and increased risk of atherosclerosis in obese children.

Authors:  Selim Gökçe; Zehra Atbinici; Zehra Aycan; Hasibe Gökçe Cınar; Pelin Zorlu
Journal:  Pediatr Cardiol       Date:  2012-08-09       Impact factor: 1.655

Review 6.  Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index.

Authors:  Qing Pang; Jing-Yao Zhang; Si-Dong Song; Kai Qu; Xin-Sen Xu; Su-Shun Liu; Chang Liu
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

Review 7.  Cirrhosis in children and adolescents: An overview.

Authors:  Raquel Borges Pinto; Ana Claudia Reis Schneider; Themis Reverbel da Silveira
Journal:  World J Hepatol       Date:  2015-03-27

8.  Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease.

Authors:  Savannah Tallino; Megan Duffy; Martina Ralle; María Paz Cortés; Mauricio Latorre; Jason L Burkhead
Journal:  J Nutr Biochem       Date:  2015-05-15       Impact factor: 6.048

9.  Treatment response in the PIVENS trial is associated with decreased Hedgehog pathway activity.

Authors:  Cynthia D Guy; Ayako Suzuki; Manal F Abdelmalek; James L Burchette; Anna Mae Diehl
Journal:  Hepatology       Date:  2014-08-25       Impact factor: 17.425

Review 10.  Drug metabolism alterations in nonalcoholic fatty liver disease.

Authors:  Matthew D Merrell; Nathan J Cherrington
Journal:  Drug Metab Rev       Date:  2011-05-25       Impact factor: 4.518

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.